FAQs & How to use this site
Home | About Us | Contact Us
The Front Line
The Front Line: Charles D. Blanke, MD, SWOG Chair
ABOUT

PREVIOUS POSTS June 2017

May 2017 April 2017 March 2017 February 2017 January 2017 December 2016 November 2016 October 2016 September 2016 August 2016 July 2016 JUNE 2016 MAY 2016 APRIL 2016 MARCH 2016 FEB 2016 JAN 2016 DEC 2015 NOV 2015 OCT 2015 SEP 2015 AUG 2015 JUL 2015 JUN 2015 MAY 2015 APR 2015 MAR 2015 FEB 2015 JAN 2015 DEC 2014 NOV 2014 OCT 2014 SEP 2014 AUG 2014 JUL 2014 JUN 2014 MAY 2014 APR 2014 MAR 2014 FEB 2014 JAN 2014 DEC 2013 NOV 2013 OCT 2013 SEP 2013 AUG 2013 JUL 2013

Continuing to expand SWOG's AYA oncology effort

Dec 6, 2013 - At a number of events over the past few months, we have been laying the groundwork and forging the partnerships needed to make our Adolescent and Young Adult Committee and research efforts successful.

Back in July the Institute of Medicine's National Cancer Policy Forum and the LIVESTRONG Foundation sponsored a workshop on addressing the needs of adolescents and young adults with cancer. In September, I attended a follow-up to that workshop -- the NCI-sponsored Next Steps for AYA Oncology meeting, which was meant to help with strategic planning by providing updates on the science of AYA oncology, reviewing scientific gaps, and exploring potential funding opportunities. We heard from several working groups that looked at AYA oncology research from the perspectives of epidemiology, biology, health services, symptom management, and clinical studies.

This led to a meeting focused on clinical trials, a historic and exciting AYA planning congress earlier this month in Cleveland with leaders from adult cooperative groups and the Children's Oncology Group. The session was co-chaired by COG and Brandon Hayes-Lattin, who represented both SWOG's AYA Committee and the Critical Mass AYA Alliance advocacy organization, of which he serves as medical director. We had a very energetic group of participants, and what came out of this first intergroup AYA oncology retreat was a nice roadmap for enhancing clinical trial design and trial accrual for these patients. We discussed many potential ways to collaborate to move AYA oncology research forward by aggregating resources, patients, and data across cooperative groups, throughout the NCI, and with key organizations such as Critical Mass, and by working together to develop specific studies.

I am proud that SWOG is helping lead the AYA effort from the adult side, as well as through active partnering with world-class experts in organizations like COG and Critical Mass.

 
     
SWOG Logo Disclaimer | Copyright ©2000-2017 SWOG. All rights reserved.
Design by nuMedia Group Inc. | Hosting by WorldPost Technologies, Inc.
SWOG is FISMA CertifiedSWOG is FISMA Certified